Syncom Formulations (India) Ltd.
SYNCOMF Share PricePharmaceuticals & Drugs
₹15.31
0 (-0.3%)
As on December 4, 2025
Exchange Scrips: BSE524470NSESYNCOMFISININE312C01025
Market Cap ₹ 1,447 Cr
P/E Ratio 29.11
Dividend Yield N/A
Performance
Market performance
Open15.2
High15.48
Volumes9,79,887
Prev15.31
Low15.2
As on2025-12-04
Historical performance
1 Year High23.87
3 Year High27.9
5 Year High27.9
1 Year Low14.1
3 Year Low4.6
5 Year Low4.6
Fundamentals
Company Valuation
Market Cap (₹Cr)
1,447
Face Value (₹)
1
P/E Ratio
29.11
Dividend Yield
N/A
Investment Returns
1 Year
-30.5%
3 Years
93.8%
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 15.47 | Bearish |
| 10-DMA | 15.57 | Bearish |
| 20-DMA | 15.92 | Bearish |
| 50-DMA | 16.34 | Bearish |
| 100-DMA | 17.08 | Bearish |
| 200-DMA | 17.56 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 13 | 13 | 13 | 13 | 13 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 13 | 13 | 13 | 13 | 13 |
| Public Investors | 457351 | 471053 | 484516 | 489507 | 469229 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 29.11.
- 3Y Stock Price CAGR of the stock is 24.4.
- The stock has a beta of 1.3.
- In the last financial year, the company had an EBITDA of ₹716 Million.
- The company generated revenue of ₹4650 Million in the previous financial year.
Syncom Formulations (India) Ltd.
15.310 (-0.3%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 687780.8
No. of Shares: 44924 (Approx)
Performance:-31.2%
P/L: ₹-312219.2
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
